Skip to main content

Hot Biotech Stocks in Focus - Aastrom Biosciences (NASDAQ:ASTM), Alexion (NASDAQ:ALXN), Ariad (NASDAQ:ARIA)

StockRunway.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.

New York, NY -- (SBWIRE) -- 04/02/2013 -- StockRunway.com issues special report on the Hot Biotech Stocks in Focus - Aastrom Biosciences (NASDAQ:ASTM), Alexion (NASDAQ:ALXN), Ariad (NASDAQ:ARIA)

Aastrom Biosciences, Inc.(NASDAQ:ASTM) moved up +9.98% with the closing price of $0.770 after a Form 8-K filing. In addition, it made partial recovery after steep fall on plan to end the late-stage trial of its drug to treat critical limb ischemia (CLI), a form of peripheral arterial disease, and reduce about 50 percent of its workforce, driving its shares to its lowest since market debut. The overall volume in the last trading session was 1.14 million shares. Its fifty two week range was $0.67-$2.72. The total market capitalization remained $33.71million.

Can ASTM Show a Strong Recovery? Find out in This Research Report

The stock is ahead its 52 week low with 14.93% and its last month price volatility remained 6.45%. Its beta coefficient was 0.05 with a target price of $1.65. In its share capital, the company has 45.66 million outstanding shares while 45.42 million shares have been floated in market.

It has insider ownership of 0.56% with its institutional ownership remained 8.97%. Its current year earnings per share grew with 25.90%.

Alexion Pharmaceuticals, Inc.(NASDAQ:ALXN) shares went 3.76% up and closed at $95.60 in the last trading session despite getting an FDA warning letter for its manufacturing plant where it manufactures its only approved drug, the rare-disease, and very pricey, Soliris. The company declared that it has backup manufacturing and inventory and was of a view that it has the matter in hand, which at least one analyst agrees with.

Should ALXN a Buy or Sell Now? Find Out Here

Its overall traded volume was 2.54 million shares. The stock’s opening price was $91.07, hitting the day high price of $95.86 and day low of $91.07. ALXN has earnings per share of $1.28 and its price to earnings ratio was 74.80. The company has 12.71% returns on assets, 16.41% returns on equity and its return on investments is 14.90%.

Ariad Pharmaceuticals, Inc.(NASDAQ:ARIA) climbed +1.22% to close at $18.30 and its total volume in the last trading session was 3.44 million shares after Jefferies Group reaffirmed its buy rating on the stock. In last 52 weeks, high hit was $25.40 and low price in that period was $14.10.

What ARIA’s Charts Are Signaling for Traders? Find Out Here

The company has outstanding shares of 166.66million with the total market cap of $3.05 billion and its beta value stands at 1.23 times. It has current ratio of 5.30 and its debt-to-equity ratio is 0.07.

About StockRunway.com
StockRunway.com is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you&aposre new to penny stocks or a seasoned veteran, you&aposll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.

Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway&aposs service today!

Disclaimer
This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.

Read Our Full Disclaimer at: http://www.stockrunway.com/disclaimer/

For more information on this press release visit: http://www.sbwire.com/press-releases/hot-biotech-stocks-in-focus-aastrom-biosciences-nasdaqastm-alexion-nasdaqalxn-ariad-nasdaqaria-231919.htm

Media Relations Contact

Bobby Delp
Email: Click to Email Bobby Delp
Web: http://www.stockrunway.com/

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.